Synthesis and antimicrobial activity of N-alkyl substituted p-methyl (E)-3- and 4-azachalconium bromides
Twenty new N-alkyl substituted p-methyl (E)-3- and 4-azachalcones (1a-j, 2a-j){3-[(1E)-3-(4-methylp-henyl)-3- oxoprop-1-en-1-yl]-1-alkyl (C_{5-12,_{14-15) pyridinium bromides (1a-j) and 4-[(1E)-3-(4-methylp-henyl)-3-oxoprop-1-en-1-yl]-1-alkyl (C_{5-12,_{14-15) pyridinium bromides (2a-j)} were synthesized and tested for antimicrobial activities against Staphylococcus aureus, Staphylococcus epidermidis, Bacillus subtilis, Enterococcus faecalis, Proteus vulgaris, and Escherichia coli. They showed good antimicrobial activity especially against the gram-positive bacteria tested with minimal inhibitory concentration (MIC) values less than 4.7 m g/mL in most cases. The optimum length of the alkyl chain for better and broader activity is situated in the range of 8-12 carbon atoms in the series of compounds 1a-j, 2a-j. The non-alkylated compounds 1-2 were not effective as were the ones alkylated with 14 or 15 C alkyl groups (1i, 1j, 2i, 2j). N-Alkyl derivatives of p-methyl (E)-3-azachalcone (1a-h) showed better activity in comparison to those of p-methyl (E)-4-azachalcone (2a-h). The antimicrobial activity increased as the length of the alkyl substitution increased from 5 to 12 carbons.
Synthesis and antimicrobial activity of N-alkyl substituted p-methyl (E)-3- and 4-azachalconium bromides
Twenty new N-alkyl substituted p-methyl (E)-3- and 4-azachalcones (1a-j, 2a-j){3-[(1E)-3-(4-methylp-henyl)-3- oxoprop-1-en-1-yl]-1-alkyl (C_{5-12,_{14-15) pyridinium bromides (1a-j) and 4-[(1E)-3-(4-methylp-henyl)-3-oxoprop-1-en-1-yl]-1-alkyl (C_{5-12,_{14-15) pyridinium bromides (2a-j)} were synthesized and tested for antimicrobial activities against Staphylococcus aureus, Staphylococcus epidermidis, Bacillus subtilis, Enterococcus faecalis, Proteus vulgaris, and Escherichia coli. They showed good antimicrobial activity especially against the gram-positive bacteria tested with minimal inhibitory concentration (MIC) values less than 4.7 m g/mL in most cases. The optimum length of the alkyl chain for better and broader activity is situated in the range of 8-12 carbon atoms in the series of compounds 1a-j, 2a-j. The non-alkylated compounds 1-2 were not effective as were the ones alkylated with 14 or 15 C alkyl groups (1i, 1j, 2i, 2j). N-Alkyl derivatives of p-methyl (E)-3-azachalcone (1a-h) showed better activity in comparison to those of p-methyl (E)-4-azachalcone (2a-h). The antimicrobial activity increased as the length of the alkyl substitution increased from 5 to 12 carbons.
___
- Agrawal, P. K.; Bansal, M. C. In Carbon-13 NMR of Flavonoids, edited by Agrawal, P. K., Elsevier, New York, 1989, pp. 365-431.
- Harborne, J. B. The Flavonoids. Advances in Research, Chapman & Hall, London, 1988, pp. 329-388.
- Nowakowska, Z.; Wyrzykiewicz, E.; Kedzia, B. Il Farmaco 2001, 56, 325–329.
- Nowakowska, Z.; Wyrzykiewicz, E.; Kedzia, B. Il Farmaco 2002, 57, 657–661.
- Nissan Chemical Industries Ltd, Japan Kokai, Tokkyo Koho J P 58,08,035; Chem. Abstr. 1983, 98, 178947a.
- Swallow, D.L. (Ed.) Progress in Drug Research, Birkhhouser Verlag, Basel, 1984, p. 140.
- Nerya, O.; Musa, R.; Khatib, S.; Tamir, S.; Vaya, J. Phytochemistry 2004, 65, 1389-1395.
- Ishitsuka, H.; Ohasawa, C.; Ohiwa, T.; Umeda, T.; Suhara,Y. Antimicrob. Agents Chemother. 1982, 22, 611-616.
- Schraufstatter, E. Experientia 1948, 4, 484-485.
- Dhar, D.N. (Ed.) The Chemistry of Chalcones and Related Compounds, Wiley, New York, 1981, p. 214.
- Nowakowska, Z. Magn. Reson. Chem. 2000, 38, 382–383.
- Jovanovi´c, B. Z.; Vukovi´c, M. M.; Marinkovi´c, A. D.; Csan´adi, J. J. Molec. Struc. 1999, 482-483, 371-374.
- Yaylı, N.; ¨U¸c¨unc¨u, O.; Ya¸sar, A.; K¨u¸c¨uk, M.; Yaylı, N.; Aky¨uz, E; Karao˘glu, S¸. A. Turk. J. Chem., 2006, 30, 505-514.
- Yaylı, N.; K¨u¸c¨uk, M.; ¨U¸c¨unc¨u, O.; Ya¸sar, A.; Yaylı, N.; Karao˘glu, S¸. A. J. Photochem. Photobiol. A: Chem. 2007, 188, 161-168.
- Usta, A.; Ya¸sar, A.; Yılmaz, N.; G¨ule¸c, C.; Yaylı, N.; Karao˘glu, S¸. A.; N. Yaylı, Helv. Chim. Acta 2007, 90, 1482-1490.
- Yaylı, N.; Ya¸sar, A.; ¨U¸c¨unc¨u, O.; Sivrikaya, S. ¨O.; G¨ule¸c, C.; K¨u¸c¨uk, M.; Abbasov, R. J. Photochem. Photobiol. A: Chem. 2005, 171, 291-298.
- Yaylı, N.; ¨U¸c¨unc¨u, O.; Ya¸sar, A.; G¨ok,Y.; K¨u¸c¨uk, M.; Kolaylı, S. Turk. J. Chem. 2004, 28, 515-521.
- Yaylı, N.; ¨U¸c¨unc¨u, O.; Ya¸sar, A.; K¨u¸c¨uk, M.; Yaylı, N. Burnaz,; N. A. Karao˘glu, S¸. A.; K¨u¸c¨uk, M. J. Photochem. Photobiol. A: Chem., 2009, 203, 85-91.
- Edwards, M. L.; Stemerick, D. M.; Sabol, J. S.; Diekema, K.A.; Dinerstein, R. J. J. Med. Chem. 1994, 37, 4357- 4362.
- Zamocka, J. Pharmazie 1993, 48, 857-859.
- Szajda, M.; Kedzia, B. Pharmazie 1991, 46, 745-746.
- Wyrzykiewicz, E.; Bartkowiak, G.; Nowakowska, Z.; Kedzia, B. Farmaco 1993, 48, 979-988.
- Tomcufcik, A.; Wilkinson, R.; Child, G. Ger. Offen Patent 1974, 2, 502, 490. Chem. Abstr. 1975, 83, P. 179067r.
- Rao, M. N.; Naidoo, L.; Ramanan, P. N. Pharmazie 1991 , 46, 542-543.
- Amelia, A.; Almeida, P.; Farah, A.; Silva, D. A. M.; Nunan, E. A.; Gloria, B. A. J. Agric. Food Chem. 2006, 54, 8738-8743.
- Demirba˘g, Z.; Beld¨uz, A. O.; Sezen, K.; Nal¸cacıo˘glu, R. K¨ukem Dergisi 1997, 20, 47-53.
- Willanova, P. A. NCCLS Document M7-A313 (25), National Committee for Clinical Laboratory Standards, USA, 1993.